Drug & intervention

timolol

RxCUI 10600

Clinical trials18

Recruiting0

Related conditions11

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

18 shown

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus LazertinibNCT06120140 · 2024-02-16

ACTIVE_NOT_RECRUITING

Interval Intraocular Pressure in Intravitreal Injection StudyNCT04868175 · 2019-10-01

A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular HypertensionNCT02742649 · 2016-04-30

Stop Retinal Ganglion Cell Dysfunction StudyNCT02390284 · 2015-09-01

Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular HypertensionNCT02312544 · 2014-11-01

The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.NCT01927406 · 2014-06-01

A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaNCT01917383 · 2013-08-01

Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionNCT01749904 · 2013-01-31

Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionNCT01749930 · 2013-01-01

Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension GlaucomaNCT01446497 · 2010-10-01

A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.NCT00716859 · 2008-07-01

Circadian Rhythms of Aqueous Humor Dynamics in HumansNCT00572936 · 2006-03-13

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaNCT00277498 · 2005-12-01

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaNCT00159653 · 2005-07-01

Comparison of Latanoprost Vs. TimololNCT00579969 · 2003-12-01

A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular HypertensionNCT00751127 · 1993-01-01

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United KingdomNCT00751049 · 1992-12-01

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within ScandinaviaNCT00751062 · 1992-11-01

Conditions being studied

Ocular Hypertension10 Glaucoma8 Open Angle Glaucoma4 Open-Angle Glaucoma3 Carcinoma, Non-Small-Cell Lung1 Glaucoma, Open-Angle1 Intraocular Pressure1 Normal Tension Glaucoma1 Ocular Hypertension (OHT)1 Primary Open-Angle Glaucoma (POAG)1 Thyroid Eye Disease1

Research locations

OmahaNebraska, United States4 Los AngelesCalifornia, United States3 LouisvilleKentucky, United States3 New YorkNew York, United States3 RochesterNew York, United States3 Ann ArborMichigan, United States2 AtlantaGeorgia, United States2 CharlestonSouth Carolina, United States2 ChicagoIllinois, United States2 ClevelandOhio, United States2 GainesvilleFlorida, United States2 HoustonTexas, United States2

Leading sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5 Bausch & Lomb Incorporated2 University of Nebraska2 ForSight Vision5, Inc.1 Inotek Pharmaceuticals Corporation1 Janssen Research & Development, LLC1 Ocular Therapeutix, Inc.1 Pfizer1 Seoul National University Hospital1 Stanford University1 The University of Hong Kong1 University of Miami1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.